Evidence map›Paper›PMID 42518997›Full record

Trial reportFrontiers in nutrition2026

Absorption kinetics of vitamins and minerals from a novel nutritional product in physically active adults: a randomized, double-blind, placebo-controlled crossover trial.

Philip A Sapp, Jeremy R Townsend, Trevor O Kirby, Caitlyn G Edwards, Michael B La Monica, Tim N Ziegenfuss, Matthew J Vergne, Wendell S Akers, Ralph Esposito

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06316700 (A Pharmacokinetic Study of a Novel Nutritional Product on Healthy Men and Women), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06316700 nacompletednot on this map

A Pharmacokinetic Study of a Novel Nutritional Product on Healthy Men and Women

TypeinterventionalSponsorAthletic Greens InternationalRan2024 to 2024Enrolled16ConditionsHealthy AgingArmsNutritional supplement, Placebo
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Philip A SappResearch, Nutrition, and Innovation, AG1, Carson City, NV, United States.
Jeremy R TownsendResearch, Nutrition, and Innovation, AG1, Carson City, NV, United States.
Trevor O KirbyResearch, Nutrition, and Innovation, AG1, Carson City, NV, United States.
Caitlyn G EdwardsResearch, Nutrition, and Innovation, AG1, Carson City, NV, United States.
Michael B La MonicaThe Center for Applied Health Sciences, Canfield, OH, United States.
Tim N ZiegenfussThe Center for Applied Health Sciences, Canfield, OH, United States.
Matthew J VergneDepartment of Pharmaceutical Sciences, Lipscomb University, Nashville, TN, United States.
Wendell S AkersDepartment of Pharmaceutical Sciences, Lipscomb University, Nashville, TN, United States.
Ralph EspositoResearch, Nutrition, and Innovation, AG1, Carson City, NV, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/objectives: Nutrient interactions in multi-ingredient supplements may influence micronutrient absorption and bioavailability, yet pharmacokinetic data exploring these interactions remains generally limited. This clinical trial assessed the acute absorption phase of key micronutrients in AG1, a comprehensive nutritional supplement containing vitamins, minerals, probiotics, and phytochemicals. Methods: In a randomized, double-blind, placebo-controlled crossover trial 16 healthy adults (8 males and 8 females) consumed a single serving (13 g) of AG1 or a taste- and appearance-matched placebo mixed in water, following a 10-h overnight fast. Each condition was separated by a 1-week washout period. Blood samples were collected 0 (baseline), 30, 60, 90, 120, 180, 240, 360, and 480 min post-ingestion. Plasma concentrations of folate, calcium, zinc, vitamin C, biotin, nicotinamide, pyridoxine, riboflavin, thiamine, and hesperidin were measured. The absorption phase was generally characterized using area under the curve (AUC Results: AG1 significantly increased AUC Conclusion: Acute consumption of AG1 resulted in measurable increases in circulating levels of most of the tested micronutrients, indicating effective absorption. These findings suggest that AG1 may influence nutrient status in healthy adults. Clinical trial registration: Clinicaltrials.gov, identifier NCT06316700.

Indexed as

bioavailabilitydietary supplementsmineralspharmacokineticsvitamins

Identifiers

PMID42518997
PMCPMC13384010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.